OTCPicks.com

For Friday, June 6th

CPRK, USSU, NXPC, XSNX, BSRC
ISPH, RUNU, TMWD, GOFH, PARL, SRSR, OPAI, FEEC

Our Stocks to Watch today include Copper King Mining Corp. (OTC: CPRK), USA Superior Energy Holdings Inc. (OTCBB: USSU), NeXplore Corp. (OTC: NXPC), XsunX Inc. (OTCBB: XSNX), BioSolar Inc. (OTCBB: BSRC), Inspire Pharmaceuticals Inc. (NASD: ISPH), Rudy Nutrition Inc. (OTC: RUNU), Tumbleweed Communications Corp. (NASD: TMWD), GoFish Corp. (OTCBB: GOFH), Parlux Fragrances Inc. (NASD: PARL), Sarissa Resources Inc. (OTC: SRSR), Orient Paper Inc. (OTCBB: OPAI) and Far East Energy Corp. (OTCBB: FEEC).

FEATURED COMPANY

IMAGE

COPPER KING MINING (OTC: CPRK)
"Up 37.50% in morning trading — up over 75% the last two days!"

Detailed Quote: http://www.otcpicks.com/quotes/CPRK.php

Company Profile:
http://www.otcpicks.com/copper-king-mining/copper-king-mining.htm

Copper King Mining Corporation currently owns approximately 1200 acres in the Drum Mountains of Utah, which are patent deeded mining claims which contain gold, silver and copper. The company recently added to its holdings by filing six more claims on land which was inside their holdings, but not patent deeded. Contiguous to that acreage is approximately 1100 acres of claims filed by Western Utah Copper Company. As the companies explored the concept of a joint venture on the Drum Mountain properties, it was decided that a very viable consideration was to join the total assets of both companies.

CPRK News:

June 3 - Copper King Mining Corporation Announces Commitment for Long-Term Financing

OCS Capital Group, LLC Delivers Permanent Financing Commitment Letter

Copper King Mining Corporation (OTC: CPRK), an ore mining, processing, and exploration company located in Milford, Southern Utah, announced that it has obtained a long-term financing commitment for the company’s copper mining and milling operations from OCS Capital Group LLC (OCS).

The OCS financing commitment represents a firm $100,000,000 project funding commitment. The funding is drawn against federal revenue bonds. The bonds, when issued, will be purchased by OCS’s investment banking house. The parties expect it to take up to 4 months to complete the entire funding. OCS is currently negotiating to assist in providing a bridge loan for the company for ongoing operational needs.

OCS, an OCS American Limited Liability Company, is an international bond-law consulting firm with offices in Pennsylvania, Washington DC, and Albuquerque, NM. It is also a consultant on government relations and government affairs. It provides technical and professional services to local, municipal, state and federal government agencies in the United States and South America.

OCS past projects have ranged from $25 Million, up to $8.3 Billion and vary from mining to commercial developments in cities and towns. Additional information will be released as approved by the lender.


FEATURED COMPANY

QMCI

USA SUPERIOR ENERGY (OTCBB: USSU)
"Up 13.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/USSU.php

Company Profile:
http://www.otcpicks.com/usa-superior-energy/usa-superior-energy-3.htm

USA Superior Energy Holdings, Inc., a development stage company, operates in the energy industry in the United States. The company, through its wholly owned subsidiary, USA Superior Energy, Inc., engages in the development, ownership, and operation of prospects and energy projects in East and Southeast Texas. It also focuses on using nitrogen technology to recharge and produce oil and gas from under-pressured partially depleted reservoirs. The company was founded in 2005 and is based in Houston, Texas.

USSU News:

June 5 - USA Superior Reports 'E' Modifier Removed From Stock Symbol

USA Superior Energy Holdings, Inc. (OTCBB: USSU) (the "Company"), a Houston-based energy company focused on acquiring, owning, operating and applying enhanced oil recovery ("EOR") techniques to existing shallow fields of oil and gas that have been idle or marginally producing, announced that yesterday the NASDAQ removed the "E" modifier from the Company's stock symbol following a review of the Company's recent filing on Friday, May 30, 2008, of its Quarterly Report on Form 10-Q/A for the three months ended March 31, 2008.

Mr. Rowland Carey, Chairman and CEO, stated: "After a significant effort on the part of the Company's accountants, auditors, legal, advisory and management teams we are very pleased to bring our recent 10-K and 10-Q filings up-to-date and to have the 'E' modifier removed from the Company's stock symbol. For the remainder of 2008 we remain focused on the workover and acceleration of revenue from our Bateman Project, strengthening our management team, increasing our capital base to fund our EOR operations and future growth and keeping our financial reporting on schedule."


FEATURED COMPANY

QMCI

NEXPLORE CORPORATION (OTC: NXPC)

Detailed Quote: http://www.otcpicks.com/quotes/NXPC.php

Company Profile: http://www.otcpicks.com/nexplore/nexplore.htm

NeXplore Technologies is developing a Web 2.0 search engine and an assortment of social networking portals and tools that will enable users to personalize their Web experience and tailor it to their unique needs, interests, and online pursuits. The Company’s social computing platform, MyCircle.com, offers an enhanced, user-friendly graphical interface search engine, combined with innovative backend technology, which enables users to improve the way they connect with information and other people on the Worldwide Web. MyCircle’s Web 2.0 interface provides users with an online tool for sharing their Blogs, Voice-Over IP, photos and documents, podcasts and videocasts, classified advertising, instant messages, SMS text messages, Chat and personal profiles.

NXPC News:

June 5 - NeXplore Corporation Transitions Newly Acquired ClickCaster.com to NeXplore Grid Server

NeXplore Leverages Grid Layer From Layered Technologies for Fast Integration, Speedy Launch, Instant Scalability

NeXplore Corporation (OTC: NXPC) announced the successful transitioning of the recently acquired ClickCaster.com website to the NeXplore Grid Server. Powered by The Grid Layer hosting solution from Layered Technologies, in combination with 3Tera Inc.'s virtualization software AppLogic, the NeXplore Grid Server is the company's virtual private data center for efficiently and cost-effectively operating and managing NeXplore's growing portfolio of Web 2.0 products and destinations.

The rapid transitioning to the NeXplore Grid Server of ClickCaster.com enables NeXplore to quickly monetize and scale this popular website that provides tools for fast-and-easy audio and video podcast creation, publishing and management. Upon acquisition by NeXplore, ClickCaster.com had approximately 245,000 unique users, a number NeXplore plans to significantly grow by the end of 2008.

NeXplore currently utilizes the NeXplore Grid Server to host and manage NeXplore Search, the company's recently launched Web 2.0 search engine optimized for a superior end-user experience, rich-media display and social network integration. NeXplore is working to integrate ClickCaster.com podcasting capability into NeXplore Search.

"The quickness, low cost and relative ease with which we were able to transition ClickCaster.com to the NeXplore Grid Server validates our decision to utilize this cutting edge hosting and application management system," said Dion Hinchcliffe, chief technology officer for NeXplore Corporation. "The pace of innovation today is blistering. Web companies hobbled by the cost and complexity associated with traditional infrastructure — datacenter co-location, private racks and managed hosting services, etc. — are destined for extinction. The road to success in today's dynamic Web 2.0 world — the path that NeXplore is forging — is paved with glitch-free performance, speed-to-market and instant, on-demand scalability."


FEATURED COMPANY

IMAGE

XSUNX INCORPORATED (OTCBB: XSNX)

Detailed Quote: http://www.otcpicks.com/quotes/XSNX.php

Company Profile: http://www.otcpicks.com/xsunx/xsunx.htm

Xsunx, Inc., a thin-film photovoltaic (TFPV) company, focuses on developing thin film photovoltaic (TFPV) amorphous silicon solar cell manufacturing processes to produce TFPV solar modules. Its product includes XsunX ASI-120 module, which is a 125 peak watt TFPV solar module utilizing glass substrates and a proprietary semiconductor manufacturing system. XsunX ASI-120 provides for a module delivering high power output, and size and framing that would allow for the use of various existing mounting systems. The target markets for the TFPV solar module include solar farms, government agencies, and utility companies, as well as power purchase agreements and large commercial installations worldwide. The company, formerly known as Sun River Mining, Inc., was incorporated in 1997 and changed its name to XsunX, Inc. in 2003. XsunX is headquartered in Aliso Viejo, California.

XSNX News:

May 29 - RedChip Visibility Initiates Research Coverage On XsunX Inc.

RedChip Visibility, a division of RedChip Companies, Inc., has initiated coverage on XsunX, Inc. (OTCBB: XSNX), a company engaged in manufacturing and commercializing thin-film photovoltaic (TFPV) solar cells utilizing amorphous silicon in the growing solar market.

Neha Bhargava, MBA, RedChip Research Analyst, reported:

“XSNX has spent the last three years focused on research with a photovoltaic material called amorphous silicon to develop an amorphous silicon thin-film photovoltaic (TFPV) solar cell manufacturing process to produce TFPV solar modules. The Company is moving in the right direction, exploiting opportunities in the thin-film solar PV market, which we believe will rapidly grow, as it offers the lowest manufacturing cost per watt at the module level and will likely maintain a cost per watt advantage over the more dominant crystalline silicon-based modules.”

“XSNX has announced plans to build a multi-megawatt, TFPV solar module production facility in Oregon. This has provided an imperative swing to XSNX's business model by focusing on the manufacturing and commercializing of TFPV solar cells and puts XSNX on the right path to seize revenue and profit opportunities in the global solar energy market as the Company heads toward commercialization of solar cells,” she continued.

“We initiate coverage of XSNX with a 'Speculative Buy' rating and a 12-month target price of $1.28,” Bhargava concluded.

To receive a complimentary copy of the RedChip Visibility Initial Research Report for XsunX Inc., visit:

www.redchip.com/visibility/about.asp?page=vreport&reportid=111&from=05292008pr.

ABOUT REDCHIP COMPANIES INC.

RedChip Companies is an international, small-cap research and financial public relations firm with offices in Maitland, Florida; Bangalore, India; and Beijing, with affiliates in New York and San Diego. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(tm), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Internet TV(tm), and RedChip Radio(tm). To learn more about RedChip's products and services, visit www.redchip.com/visibility/productsandservices.asp.


FEATURED COMPANY

QMCI

BIOSOLAR INCORPORATED (OTC: BSRC)

Detailed Quote: http://www.otcpicks.com/quotes/BSRC.php

Company Profile: http://www.otcpicks.com/biosolar/biosolar-2.htm

BioSolar, Inc. engages in the research and development of bioplastic materials from renewable plant sources for use in photovoltaic solar cells. The company develops bio-based plastics components that meet the thermal and durability requirements of solar cell manufacturing processes for conventional crystalline cell designs, as well as thin film photovoltaic devices in an effort to capitalize on cost advantages to current petroleum based solar cell components. Its bioplastic materials can be also used directly in conventional manufacturing systems, such as injection molding and thin-film roll-to-roll, to create superstrate layer, substrate layer, and backsheet, as well as module and panel components. The company was founded in April 2006. It was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. is headquartered in Santa Clarita, California.

BSRC News:

May 19 - BioSolar's Dr. Stan Levy Selected to Present Company's Breakthrough BioBacksheet™ Solar Cell Technology at Key Industry Meeting

Chief Technology Officer to Speak at SPIE, the Largest Optical Science and Technology Meeting in North America

BioSolar(TM), Inc. (OTCBB: BSRC), developer of a breakthrough technology to produce bio-based materials from renewable plant sources that reduce the cost of photovoltaic solar cells, announced that Dr. Stan Levy, the company's Chief Technology Officer, will present at the SPIE Symposium on Solar Applications and Energy conference on Tuesday, August 12, 2008 in San Diego, CA.

Dr. Levy will present findings from the company's technology development program, which led to BioSolar's breakthrough photovoltaic cell component, the BioBacksheet(TM). He will speak to thousands of engineers and researchers gathered for the SPIE symposium, the largest optical science and technology meeting in North America.

"Dr. Levy has spearheaded our technology development efforts, and in a highly efficient fashion, delivered a uniquely sophisticated product that has stimulated interest on the part of a significant number of major solar cell manufacturers," said Dr. David Lee, CEO of BioSolar. "The submissions panel at the SPIE Symposium on Solar Applications and Energy recognizes the unique nature of our new product and has asked Dr. Levy to deliver an oral presentation, rather than the more common poster presentation. This forum will allow Dr. Levy to discuss in detail the various scientific breakthroughs underlying our BioBacksheet(TM)."

BioSolar recently announced that the company has delivered BioBacksheet(TM) samples to a select group of solar cell manufacturers in multiple regions of the country. BioSolar also has received numerous requests for analysis samples from high-volume manufacturers, located in the U.S. and abroad.

"The high level of industry interest in our new product and Dr. Levy's invitation to speak at SPIE are tributes to the significance of his contributions to BioSolar and our shareholders," said Dr. Lee.

ABOUT SPIE

SPIE is an international membership society, serving scientists and engineers in industry, academia, and government, as well as companies producing leading-edge products. SPIE constituents work in a wide variety of fields that utilize some aspect of optics and photonics, which is the science and application of light. SPIE Optics+Photonics is the largest optical sciences and technology meeting in North America, including over 55 courses and workshops. The Solar Energy + Applications track of the conference is dedicated to finding ways to move toward secure, affordable, and environmentally sustainable energy to meet the world's accelerating energy needs. For more information, visit http://spie.org/solar-energy.xml.


STOCKS TO WATCH

INSPIRE PHARMACEUTICALS INCORPORATED (NASD: ISPH)
"Up 44.16% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ISPH.php

Inspire Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products for diseases in the ophthalmic and respiratory areas. Inspire is currently developing products for dry eye, cystic fibrosis and glaucoma. Inspire employs a U.S. sales force for the promotion of AzaSite® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat® (epinastine HCI ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis® (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Elestat and Restasis are registered trademarks owned by Allergan, Inc. AzaSite is a registered trademark owned by InSite Vision Incorporated. For more information, visit www.inspirepharm.com.

ISPH News:

June 6 - Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis

Detailed Results to Be Presented at North American Cystic Fibrosis Conference in October 2008

Inspire Pharmaceuticals, Inc. (NASD: ISPH) announced top-line results from the 352-patient, double-blind, 24-week placebo-controlled portion of its Phase 3 trial (TIGER-1) with denufosol tetrasodium inhalation solution for the treatment of cystic fibrosis (CF).

The trial demonstrated statistical significance for its primary efficacy endpoint, which was the change in FEV1 (Forced Expiratory Volume in One Second) from baseline at the trial endpoint (at 24 weeks or last observation carried forward). Patients treated with denufosol had a statistically significant improvement in FEV1 compared to placebo (45 milliliter treatment group difference, p = 0.047). On average, patients on denufosol improved relative to baseline whereas patients on placebo remained essentially unchanged. The treatment effect of denufosol increased over the 24-week placebo-controlled period, and available preliminary data from approximately 210 patients who have completed the ongoing open-label safety extension (including the placebo patients switched to denufosol) suggest that FEV1 continued to improve during the extension period from weeks 24 to 48.

Secondary endpoints were also evaluated in the trial. There was a trend in differences in FEF (25%-75%) (Forced Expiratory Flow 25%-75%), a measure of small airway function, favoring denufosol over placebo (p = 0.072). There were no statistically significant differences between denufosol and placebo relative to pulmonary exacerbations. Data analysis is ongoing for various other pre-specified secondary endpoints and sub-groups.

For the 352 subjects randomized, the treatment groups were balanced with respect to key demographic and background characteristics: the mean age was approximately 14.6 years old, the mean lung function at baseline was 92% of the predicted normal value of FEV1, and the use of concomitant medications included inhaled antibiotics (37%), dornase alfa (Pulmozyme®) (77%) and oral macrolide antibiotics (40%). Approximately one-half of patients were receiving three or more pulmonary medications for the treatment of their disease during the course of this trial. This trial demonstrated that the effects of denufosol on FEV1 were beneficial in this population of patients taking multiple commonly-prescribed CF pulmonary medications.

Denufosol was well-tolerated and had a favorable safety profile in the trial. Patient retention rates were high and similar between treatment groups with approximately 90% of patients completing the 24-week placebo-controlled portion. The incidence of adverse events in the denufosol group was comparable to placebo. As in previous trials, the most common adverse event was cough, which was similar in both groups. There were no apparent treatment effects with respect to height, weight or body mass index. The clinical laboratory profiles were similar between the groups. Seven patients withdrew due to adverse events (five denufosol and two placebo recipients).

Following the 24-week placebo-controlled period, approximately 315 patients continued into the open-label safety extension portion of the trial and approximately 213 of those patients have now completed the full trial for a total of 48 weeks. The patient discontinuation rate in the open-label safety extension is currently less than 4%.

Frank J. Accurso, M.D., Professor of Pediatrics and Cystic Fibrosis Center Director, University of Colorado and The Children’s Hospital Denver, and lead principal investigator of TIGER-1, stated “The results from this trial are exciting because they demonstrate that denufosol’s novel mechanism of action, activation of an alternative chloride channel that is treating the underlying defect, had a clinically-meaningful impact on lung function that progressively increased over time. The improvement in FEV1 was achieved on top of aggressive use of multiple concomitant medications, such as inhaled antibiotics, dornase alfa and oral macrolide antibiotics. The benefit in lung function observed in these relatively young patients, with a mean age of around 14 years, was encouraging. In particular, adolescence is an especially vulnerable time for these patients, where lung function generally declines. In this trial, denufosol had a favorable safety profile and provided benefit to CF patients.”

Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation, commented, “The data from this Phase 3 trial with denufosol are encouraging for the cystic fibrosis community because it brings us one step closer to a novel treatment that addresses the basic cystic fibrosis defect. There remains a high unmet medical need in the area of CF treatments and denufosol could be an important addition to the treatment regimen. The Foundation has worked closely with Inspire from the beginning of this program and provided funding for a key Phase 2 clinical trial. This validates our business model to support highly innovative potential new treatments for CF.”

“We are pleased that denufosol met the primary efficacy endpoint in TIGER-1 and we will continue to work toward bringing this new treatment to the cystic fibrosis community,” stated Christy L. Shaffer, Ph.D., President and CEO of Inspire. “We would like to thank the Cystic Fibrosis Foundation, the Therapeutics Development Network and all of the dedicated patients, investigators, and study coordinators who participated in TIGER-1. We also want to thank the patients’ families for their support and interest in denufosol. We plan to use the valuable information generated in this trial to further optimize TIGER-2 which began enrolling patients a few months ago.”

Next Steps

Additional analyses are ongoing and next steps in the program will be discussed with key advisors from the CF medical community and the U.S. Food and Drug Administration (FDA). Data from this trial have yet to be reviewed by the FDA. The Company continues to expect that results from the ongoing development work including the TIGER-1 open-label safety extension, TIGER-2 (the second pivotal Phase 3 trial), and a two-year pre-clinical carcinogenicity study, will be necessary for filing a new drug application (NDA) for denufosol. Detailed data from TIGER-1 will be presented at the North American Cystic Fibrosis (NACF) conference scheduled for October 23-25, 2008 in Orlando, Florida. The results from the ongoing open-label extension phase of TIGER-1, in which all patients are receiving denufosol, are expected to be available in the first quarter of 2009.

ABOUT DENUFOSOL TETRASODIUM

Based on pre-clinical and clinical work, denufosol tetrasodium has several pharmacological actions contributing to its mechanism of action: hydration of the airways by stimulating chloride and liquid secretions on the epithelial cell surface; inhibition of epithelial sodium absorption; enhancement of ciliary beat frequency; and stimulation of mucin secretion. Denufosol for the treatment of cystic fibrosis has been granted Fast Track designation and orphan drug status in the United States by the FDA and orphan drug designation in Europe by the European Medicines Agency (EMEA). Inspire holds world-wide rights for denufosol.

ABOUT TIGER-1

TIGER-1 (08-108) is the first of two planned pivotal Phase 3 trials with denufosol for the treatment of cystic fibrosis. TIGER-1 included a 24-week placebo-controlled portion, followed by a 24-week open-label safety extension, which is ongoing. The placebo-controlled portion was a double-blind, randomized trial comparing 60 mg of denufosol to placebo, administered three times daily by jet nebulizer, in 352 patients with mild cystic fibrosis lung disease (baseline FEV1 ≥ 75% of predicted normal).

ABOUT CYSTIC FIBROSIS

Cystic fibrosis is a life-threatening disease involving a genetic mutation that disrupts the cystic fibrosis transmembrane regulator (CFTR) protein, resulting in poorly hydrated, thickened mucous secretions in the lungs, as well as severely impaired mucociliary clearance. According to the U.S. Cystic Fibrosis Foundation (CFF), there are approximately 30,000 cystic fibrosis patients in the United States and the median life expectancy for patients is approximately 37 years (CFF Patient Registry Annual Data Report 2006).


RUDY NUTRITION INCORPORATED (OTC: RUNU)
"Up 46.67% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/RUNU.php

Founded by Notre Dame sports legend Daniel "Rudy" Ruettiger, Rudy Nutrition, Inc. is a manufacturer of health conscious "Rudy" branded products that offer great taste as well as healthy choices for parents, kids, athletes, and active people looking for something special. Rudy Nutrition is focused on creating, distributing and licensing "Rudy" branded products that offer healthier alternative choices backed by Rudy's inspirational message of hope — that "never give up" spirit immortalized in the movie "RUDY" — on every product. For more information, visit www.rudynutrition.com, www.rudybeverageinc.com or www.avcg.net.

RUNU News:

June 6 - Coach June Jones Joins the Rudy Nutrition Team

Rudy Nutrition, Inc. (OTC: RUNU) announced that Southern Methodist University head football coach June Jones has joined the Rudy Beverage team as a celebrity endorser. Coach Jones will make personal appearances on behalf of Rudy Beverage and will be featured in advertising and promotional campaigns.

Before accepting the position at SMU, June Jones served as head football coach at the University of Hawai'i, San Diego Chargers and Atlanta Falcons. While at Hawai'i, Coach Jones was named National Coach of the Year (1999), led his team to the only NCAA Division I undefeated regular season (2007) and a birth in the BCS, Nokia Sugar Bowl (2008). He is the winningest football coach in University of Hawai'i history.

"Football players will love the great taste, superior nutritional value, and optimum hydration of Rudy Beverage," said June Jones. "I am very excited to be joining Rudy in sharing this fantastic product with others and spreading his inspirational message of dreaming big and never quitting. I am a Rudy Ruettiger fan."

Daniel "Rudy" Ruettiger, Founder and Chairman of Rudy Nutrition commented: "June Jones' numerous accomplishments on and off the field exemplify what the Rudy message is all about. I am so proud to have this great mentor of so many young people join our team. June Jones is a winner and is my friend."

In the coming weeks, additional nationally recognized sports personalities who embody the Rudy message of "Dream Big. Never Quit." will to be announced.


TUMBLEWEED COMMUNICATIONS CORPORATION (NASD: TMWD)
"Up 46.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/TMWD.php

Tumbleweed Communications Corp. provides managed file transfer, email security, and identity validation products to enterprise and government customers worldwide. Its solutions enable organizations to safely and confidently conduct business over the Internet, protecting data in motion and at rest with intuitive, pragmatic solutions that promote collaboration, prevent data loss, and reduce the cost of doing business. The company offers SecureTransport, an enterprise-class managed file transfer solution that enables customers to securely manage the exchange of large files and transactions without having to change internal infrastructure; Secure Messenger, a policy-based email encryption product, which enables deep-content inspection of incoming and outgoing mail, and dynamic application of user-defined encryption and routing preferences; MailGate, a comprehensive email security product that provides inbound and outbound protection with protection against virus outbreaks, spam, and denial of service attacks, eliminating illegitimate email traffic before it can penetrate corporate firewalls; and Validation Authority, a product for determining the validity of digital certificates. The company sells its products directly and through channel partners to enterprises in the financial services, healthcare, and government markets. The company was founded in 1993 and is based in Redwood City, California.

TMWD News:

June 6 - Sopra Group Subsidiary Axway Announces a Plan of Merger with Tumbleweed Communications

Sopra Group (Euronext Paris: SOP) and Tumbleweed Communications (NASD: TMWD) announced a plan of merger in which Sopra Group, via its subsidiary Axway, would acquire all the outstanding Tumbleweed stock in cash at $2.70 per share. The proposed transaction is subject to customary closing conditions including regulatory and Tumbleweed stockholder approvals, and is expected to close in the third calendar quarter of 2008. Tumbleweed’s operations will then be combined with those of Axway. Together, Axway and Tumbleweed will offer integrated collaborative business solutions to more than 11,000 customers globally.

Tumbleweed provides Secure Content Delivery Solutions to more than 3,300 customers in various industries including financial services, healthcare and government. Tumbleweed reported revenue of $57 million (approximately €38 million) in fiscal 2007. Sopra Group intends to merge the businesses of Tumbleweed with those of its subsidiary, Axway, a leading global provider of collaborative business solutions which reported fiscal 2007 revenue of €145 million ($218 million) and a 10% EBIT margin.

Sopra Group expects this transaction to be accretive. In 2009, the combined entity of Axway and Tumbleweed expects to generate revenue of around €230 million with an operating margin between 12-15%.

The CEO of Axway, Christophe Fabre, and the CEO of Tumbleweed, Jim Scullion, share a common vision about the market and the solutions required to drive it. According to Scullion, “Tumbleweed is a natural fit with Axway. We are confident that the combined product offering will benefit customers from both companies and increase long-term growth prospects.”

Fabre adds, “The combined entity is expected to more than double Axway’s North American revenue. In addition, our respective customers will have access to a highly attractive set of products, solutions and services.”

The proposed transaction has been approved by Sopra Group’s Board of Directors. Tumbleweed’s Board of Directors also approved the transaction and will recommend that its shareholders accept the offer. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to close in the third quarter of 2008.

Sopra Group expects to fund the transaction through its existing lines of credit. Given the complementary nature of Axway’s and Tumbleweed’s businesses, Sopra Group expects to recognize synergies through both revenue growth and cost savings.


GOFISH CORPORATION (OTCBB: GOFH)
"Up 26.09% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/GOFH.php

GoFish Corporation (www.gofishcorp.com), headquartered in San Francisco with offices in Los Angeles and New York, is a leading entertainment and media company, with a focus on reaching kids, teens and moms, and specializing in aggregating, and distributing premium content on a large network of quality sites for which GoFish is the exclusive brand advertising monetization partner. The GoFish Network of sites reaches nearly 21 million unduplicated online users domestically, and over 66 million worldwide. GoFish has been a pioneer in online content appealing to the hard-to-reach youth market and their parents. It presently ranks as the 3rd largest kids/teens opportunity and a top 5 ‘mom’ opportunity for blue-chip advertisers.

GOFH News:

June 6 - GoFish Corporation Names Tribal DDB Worldwide Founder and CEO Matt Freeman as Chief Executive Officer, Board Director

Move Extends GoFish Leadership in Creation of Digital Brand Immersion Network for Major Advertisers

GoFish Corporation (OTCBB: GOFH), a leading online media company with nearly 21 million unique users a month domestically and 66 million a month worldwide, named Matt Freeman, former Founder and Chief Executive Officer of Tribal DDB Worldwide, as Chief Executive Officer and a member of the Company’s Board of Directors. He succeeds Michael Downing who will leave the company.

“Companies like McDonald’s and Nike cannot build their brands through buying search keywords alone,” says Mr. Freeman. “As online audiences continue to fragment beyond the portals, major brands still need a way to connect with mass audiences. GoFish offers advertisers meaningful brand engagement, not merely direct response, across an ever-expanding portfolio of digital properties that are at the vanguard of consumers’ passions and interests.”

“Matt is a seminal figure in the digital marketing and advertising industry. He is an experienced, entrepreneurial chief executive with a proven track record of building businesses in highly competitive domestic and international markets. His broad-based experience includes running industry leading companies from their earliest stages to mature market leadership and delivering exceptionally high levels of revenues and profit,” says Tabreez Verjee, President of GoFish. “We are excited to have him take day to day responsibility for GoFish as we expand our well positioned vertical advertising business and establish ourselves as a digital entertainment media company.”

Mr. Freeman adds, “Since its successful launch this past February, the immersive experience that GoFish Network uniquely offers has allowed it to grow to nearly 21 million unique users domestically and 66 million unique users worldwide, becoming one of the ‘Big 3’ youth brands on the Internet. Even more exciting to me is GoFish’s proven ability to expand its ‘Brand Immersion’ approach in advertising to Young Adults and Moms demos, underscoring the company’s huge potential to provide brand advertisers a premium environment with a highly-engaged audience no matter who the target. This is a company with an exceptionally promising future.”

Mr. Freeman helped found Tribal DDB Worldwide in 1998 growing the company from 45 employees and $5 million in annual revenue to over 1,500 employees and $250 million in annual revenue while building a global network of 45 offices spanning 28 countries. He developed broad, global relationships with Fortune 100 clients including PepsiCo, Philips, Johnson & Johnson, McDonald’s, Volkswagen, ExxonMobil and Unilever. Mr. Freeman also started and scaled specialized business units in Search (SEM & SEO), Hosting, Database development & Analytics (including proprietary econometric modeling applications), Digital Healthcare Marketing, Gaming, Mobile, iTV and Strategic Consulting.

In January 2006, AdWeek named Tribal DDB Worldwide its Interactive Agency of the Year and in January 2008, Adverting Age awarded it Global Agency Network of the Year. Both publications cited Mr. Freeman’s leadership as a critical factor in Tribal’s enduring success.

In 1997 and 1998, Mr. Freeman was Executive Creative Director Modem Media / Poppe Tyson (since then acquired by Digitas, Inc.; now a Division of Publicis Group). There, he led efforts on IBM & other key clients and was part of the merger integration team with Modem Media and Poppe Tyson. Before that, he was Partner, Executive Creative Director at Poppe Tyson (formerly a division of True North, now Interpublic Group from 1995 to 1997. Earlier in his career, Mr. Freeman was a writer at MTV working on Beavis & Butthead and MTV Beach House and he was a private school English teacher.

Mr. Freeman, a graduate of Dartmouth College and the NY School of Visual Arts, has been inducted into the American Advertising Federation Hall of Achievement; is the Founder of the Interactive Agency Board of the IAB, is an active Board member of the Advertising Club and the American Association of Advertising Agencies (4As) and is a member of the Marketing Advisory Board of the Modern Museum of Art (MOMA).


PARLUX FRAGRANCES INCORPORATED (NASD: PARL)
"Up 28.82% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PARL.php

Parlux Fragrances, Inc. is a manufacturer and international distributor of prestige products. It holds licenses for Paris Hilton fragrances, watches, cosmetics, sunglasses, handbags and other small leather accessories in addition to licenses to manufacture and distribute the designer fragrance brands of GUESS?, Jessica Simpson, Nicole Miller, Natori, Queen Latifah, XOXO, Ocean Pacific (OP), Maria Sharapova, Andy Roddick, babyGund, and Fred Hayman Beverly Hills.

PARL News:

June 5 - Parlux Fragrances, Inc. Announces Fiscal 2008 Earnings

Parlux Fragrances, Inc. (NASD: PARL) announced its results for the fiscal year ended March 31, 2008. Sales from continuing operations were $153,696,374 compared to $134,365,094 in the prior year, an increase of 14%.

Income from continuing operations was $5,010,751 compared to a loss of ($27,864,295) in the prior year. Net income including discontinued operations was $5,036,101, or $0.24 per diluted share compared to $2,882,232 or $0.16 per diluted share in the prior year.

Mr. Neil Katz, Chairman and CEO, noted that, "The Company achieved a $51 million improvement in income from continuing operations before income taxes, on a year to year basis, which underscores our success in restructuring our operations and refocusing our business. We have reduced our operating costs by 33% by centralizing warehousing/distribution in New Jersey, and moving all corporate management and administrative activities into new office facilities in South Florida. We have reduced inventories by 35%, reduced G&A by 39% (excluding non-cash share-based compensation charges of $244,662 in 2008 and $18,946,950 in 2007), and reduced advertising by 22%, while concurrently increasing sales by 14%."

"Most significantly," Mr. Katz continued, "the Company had over $21 million in cash on hand at year end, and our $35 million bank line was not utilized. These funds will be available to support the launch of new licenses which we have signed, specifically Jessica Simpson, Nicole Miller, Natori and Queen Latifah, and to fully support our ongoing base business of Paris Hilton and GUESS?. Additionally, we will be launching a new Paris Hilton fragrance this Fall, as well as a new GUESS? men's fragrance in the Spring of 2009."

"We are optimistic about the growth and profit potential of the Company in Fiscal 2009 and the future," Mr. Katz concluded.

The financial results for fiscal 2008 are attached. The Company will file its Annual Report on Form 10-K for the fiscal year ended March 31, 2008 as soon as possible.


SARISSA RESOURCES INCORPORATED (OTC: SRSR)
"Up 15.62% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/SRSR.php

Sarissa Resources is an American junior exploration company that identifies and explores mineral properties in North America. Currently, Sarissa has interests in properties with base metal, precious metal, uranium and niobium prospects in Northern Ontario, Canada.

SRSR News:

June 5 - Sarissa Resources CEO Issues Shareholder Update

Sarissa Resources, Inc.'s (OTC: SRSR) CEO, Scott Keevil, issued a letter to shareholders providing a general corporate update and outlining recent developments and key ongoing initiatives. The letter reads as follows:

Dear fellow Sarissa Resources shareholders,

Since taking on the leadership role with Sarissa just 6 months ago, I have had the opportunity to direct and oversee the acquisition of an outstanding mineral property for our company, the Nemegosenda carbonatite property, and to begin to formulate the strategy for an exploration and confirmation program. We have made phenomenal progress in this short time, effectively graduating from a very junior exploration company with exciting yet undeveloped potential, to a company with ownership of a world-class asset, one with a historic reserve base reported at 20 million tons of 0.47% Nb2O5 material, as outlined initially by Dominion Gulf Company.

Moving forward, the immediate goal for Sarissa will be to confirm and rapidly increase the size of the historic 20 million ton resource base at Nemegosenda. While we have no control over world markets or the value of resources, we do have control over the definition of those resources. To that end, a significantly larger resource base will be aggressively pursued through confirmation of the main ore zone; explorations for extensions of the main ore zone; more detailed analysis for possible additional values in uranium, tantalum and rare earth elements; exploration on the East Zones to further define the known niobium occurrences there; as well as exploration on some of the under-explored areas of our property. Fortunately, we happen to be living in a day and age when we are able to apply modern exploration and analysis techniques to the property that may not have been available to the geologists working for Gulf Minerals approximately 50 years ago when Nemegosenda was first explored.

Leading the charge on this front, we have been fortunate to attract some top-notch geological talent to the Board of Directors to assist us in analyzing the historic data, and in planning and implementing ongoing exploration activities: Dr. Cam Cheriton, a Harvard University educated Economic Geologist with a vast knowledge of the geology of Northern Ontario; and Alan Hawke, a seasoned exploration geologist with outstanding credentials both in mineral exploration and in mine building.

In March we began the process of independently assessing the historic geological work done on the property and developing an exploration plan to bring the deposit into NI 43-101 compliance. The results of that independent assessment confirmed that, "based on a comparison of the Dominion Gulf and OGS [Ontario Geological Survey] historical work done to date... is detailed and of high quality." Further, "The detailed work of the OGS in the 1970s and 80s has largely confirmed the interpretations and the historical exploration work of Parsons and the Dominion Gulf Company."

Alan Hawke has begun the process of having the extensive database of geological information that we have digitized, including the data from the drill logs of more than 60 holes comprising some 35,000 feet of drilling. This will allow us to generate a fairly complete 3-dimensional model of the main ore zone, allowing us to very specifically target the drilling we need in order both to confirm and to expand on this zone. Once the data is in electronic form we will have a geological consulting firm translate it into a 3-dimensional model. The combination of all this data into one easily-managed model should greatly assist us in our ongoing exploration and development of Nemegosenda, both in targeting and in economizing our overall exploration expenditures.

In recent days and weeks, the Company has had a crew working at the site on road rehabilitation. The crew has completed a 600 meter drill path from one of the ancillary lumber roads into the Main D Zone and work is continuing on the existing network of lumber roads to upgrade them to allow heavy equipment to be delivered to the site. Additionally, Sarissa has received verbal information from a local source that entered and followed the 580-foot adit in August of 2007 to the end and has reported that it is dry and in good shape for rehabilitation, an assessment that Sarissa will next endeavour to confirm.

With respect to the Company's financial footing, we have recently retained the services of an auditing firm to audit the consolidated financial statements of Sarissa Resources in accordance with Generally Accepted Accounting Principals (GAAP) and to provide the Company's Board of Directors with an opinion on them in accordance with the standards of the Public Company Accounting Oversight Board (United States), and we are currently in the midst of that process. This will be another step in our progress toward improving the company's corporate and listing structure.

As far as financing the Company's growth is concerned, the Company's management team is committed to accessing capital in a responsible manner having recently completed a few small private placements of restricted shares to raise the necessary funds to complete these early stages of our evolution. Furthermore, we are committed to continue to balance our capital requirements with our desire to maintain a reasonable share structure through judicious placement activities. All told, after accounting for recent private placements and share issuances in which 14,250,000 Sarissa Resources shares were allocated, the Company's fully diluted capital structure is comprised of 740,116,058 common shares outstanding, of which 264,030,000 are restricted.

In summation, the vast scale of this exciting exploration target requires a professional approach to determine the ultimate extent of the deposits, and both I and the rest of the management team are motivated by the potential of this project and look forward to reporting new results and developments as they occur. We are excited about the potential that lies ahead and thank you for your patience, loyalty and your continued support as we move forward. We can only hope that the next 6 months will be as exciting and productive as the first 6 have been and we will continue to communicate regularly on our progress as we strive to reach our goals.


ORIENT PAPER INCORPORATED (OTCBB: OPAI)
"Up 30.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/OPAI.php

Orient Paper engages mainly in the production and distribution of products such as copy paper, uncoated and coated paper, digital photo paper, corrugated paper, plastic paper, kraft paper, graphic design paper, antifraud thermal security paper and other paper and packaging-related products. For more information, visit www.orientalpapercorporation.com.

OPAI News:

June 4 - Orient Paper Expects to Produce $40M in Revenues from Conversion to Anti-Counterfeit Paper Production Line

Orient Paper Inc. (OTCBB: OPAI) (the “Company”), a large paper milling manufacturer announced recently that its wholly-owned subsidiary, Hebei Baoding Orient Paper Milling Co, Ltd, has started to transform the current anti-counterfeit production line, planning to complete this transformation within the next several months. The market price of this paper is approximately $2,000 to $4,500 per ton and the Company expects to produce a minimum of 10,000 tons annually in the first year.

Anti-counterfeit paper, using advanced technology to insert security lines, which are gold or plastic lines, will become one of the Company’s major products. Various anti-counterfeit patterned papers are produced by putting colored fiber into white pulp to create visibly patterned, shaded paper. This paper is used widely in printing various valuable securities.

Mr. Zhenyong Liu, CEO of Orient Paper stated, “Once the transformation of the production line has been accomplished, we expect to be able to produce 10,000 tons or more within the first year of production. This equates to approximately $40 million in revenues for our Company and $6 million in net profits. Simultaneously, we will be upgrading our products, and entering the high-grade paper industry which will open up additional revenue streams to the Company in the future. This will lay a solid foundation for the Company to have sustainable growth in the future and provide enhanced returns to our shareholders.”


FAR EAST ENERGY CORPORATION (OTCBB: FEEC)
"Up 18.99% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/FEEC.php

Based in Houston, Texas, with offices in Beijing, Kunming, and Taiyuan City, China, Far East Energy Corporation is focused on CBM exploration and development in China through its agreements with ConocoPhillips and China United Coalbed Methane

FEEC News:

June 5 - Far East Energy Announces Operations Update Call

Far East Energy Corporation (OTCBB: FEEC) announced that it will host an operations update call Wednesday, June 11th, 2008 at 10:00 a.m. Central Time. Michael R. McElwrath, CEO and President, will introduce and be joined by Phil Christian, newly appointed Chief Operating Officer (COO), during which time Mr. Christian will provide an update on operations and highlight the Company’s drilling plan.

To access this event, please go to the Far East Energy web-site, or dial 1-866-412-1097 (U.S. participants), or 1-706-634-5763 (International participants). The pass code for all callers is 50671464. Questions submitted by call participants will be taken via the Company’s website only.

 
< Prev   Next >
Clicky Web Analytics